Table 2. Prevalence of G6PD deficiency according to gender.
Severity | Number | Male | Femalea | X2 | P value | |
---|---|---|---|---|---|---|
TH Anuradhapura (Males: nb = 313; 95% CIc: 56.99–64.89) (Females: nb = 705; 95% CIc: 52.20–57.02) | ≤10% | 28 | 7 (2.24%) | 21 (2.98%) | 0.45 | 0.504 |
>10–30% | 114 | 28 (8.95%) | 86 (12.20%) | 2.31 | 0.129 | |
Total | 142 | 35 (11.18%) 95% CIc: 11.25–24.91 | 107 (15.18%) 95% CIc: 14.78–22.72 | 2.88 | 0.089 | |
TH Kurunegala (Males: nb = 313; 95% CIc: 55.82–63.02) (Females: nb = 728; 95% CIc: 53.85–58.25) | ≤10% | 17 | 7 (2.24%) | 10 (1.37%) | 1.01 | 0.314 |
>10–30% | 66 | 18 (5.75%) | 48 (6.59%) | 0.26 | 0.609 | |
Total | 83 | 25 (7.99%) 95% CIc: 7.20–22.96 | 58 (7.97%) 95% CIc: 10.29–20.99 | <0.01 | 0.991 |
aPrevalence of G6PD deficiency was significantly greater among females in Anuradhapura than in Kurunegala (P<0.05).
bn denotes the number of samples.
c95% CI denotes the interval within which lies the mean percentage level of G6PD enzyme in the population predicted at a 95% level of confidence.